ヒドロコルチゾンの世界市場2020-2028：疾患別（副腎皮質機能不全、アドレナリン作動性症候群、高血中カルシウム、甲状腺炎、関節リウマチ、皮膚炎、喘息および慢性閉塞性肺疾患[COPD]、その他）、投与経路別、流通経路別

• 英文タイトル：Hydrocortisone Market (Indication: Adrenocortical Insufficiency, Adrenergic Syndrome, High Blood Calcium, Thyroiditis, Rheumatoid Arthritis, Dermatitis, Asthma and Chronic Obstructive Pulmonary Disease [COPD], and Others; Route of Administration: Parenteral, Oral, Topical, and Rectal; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2028

• レポートコード：TMR2006016 • 出版社/出版日：Transparency Market Research / 2020年3月 • レポート形態：英文、PDF、164ページ • 納品方法：Eメール • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、ヒドロコルチゾンの世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、疾患別（副腎皮質機能不全、アドレナリン作動性症候群、高血中カルシウム、甲状腺炎、関節リウマチ、皮膚炎、喘息および慢性閉塞性肺疾患[COPD]、その他）分析、投与経路別分析、流通経路別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ）分析、企業概要などを総合的に調査・分析して掲載しております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・キーインサイト ・ヒドロコルチゾンの世界市場規模：疾患別（副腎皮質機能不全、アドレナリン作動性症候群、高血中カルシウム、甲状腺炎、関節リウマチ、皮膚炎、喘息および慢性閉塞性肺疾患[COPD]、その他） ・ヒドロコルチゾンの世界市場規模：投与経路別 ・ヒドロコルチゾンの世界市場規模：流通経路別 ・ヒドロコルチゾンの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ） ・企業概要

Hydrocortisone Market – Scope of the Report

TMR’s report on the global hydrocortisone market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2028. The report provides the revenue of the global hydrocortisone market for the period 2018–2028, considering 2019 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global hydrocortisone market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hydrocortisone market.

Secondary research also included internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global hydrocortisone market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global hydrocortisone market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global hydrocortisone market.

The report delves into the competitive landscape of the global hydrocortisone market. Key players operating in the global hydrocortisone market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global hydrocortisone market that have been profiled in this report.

Key Questions Answered in Hydrocortisone Market Report

What is the scope of growth of companies in the global hydrocortisone market?
What will be the Y-o-Y growth of the global hydrocortisone market between 2020 and 2028?
What is the influence of changing trends in technologies on the global hydrocortisone market?
Will North America continue to be the most profitable market for hydrocortisone providers?
Which factors will hamper the growth of the global hydrocortisone market during the forecast period?
Which are the leading companies in the global hydrocortisone market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global hydrocortisone market and arrive at conclusions on the growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the production of the global hydrocortisone market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who have contributed to the production of TMR’s study on the hydrocortisone market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from hydrocortisone market leaders. Access to extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global hydrocortisone market with accuracy. The study also uses the top-down approach to assess the revenue numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global hydrocortisone market more reliably and accurately.

レポート目次

---

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Hydrocortisone Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Hydrocortisone Market Analysis and Forecast, 2018–2028

5. Key Insights

5.1. Regulatory Scenario, by Region/globally

6. Global Hydrocortisone Market Analysis and Forecast, by Indication

6.1. Introduction

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Indication, 2018–2028

6.3.1. Adrenocortical Insufficiency

6.3.2. Adrenergic Syndrome

6.3.3. High Blood Calcium

6.3.4. Thyroiditis

6.3.5. Rheumatoid Arthritis

6.3.6. Dermatitis

6.3.7. Asthma and Chronic Obstructive Pulmonary Disease (COPD)

6.3.8. Others

6.4. Market Attractiveness, by Indication

7. Global Hydrocortisone Market Analysis and Forecast, by Route of Administration

7.1. Introduction

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Route of Administration, 2018–2028

7.3.1. Parenteral

7.3.2. Oral

7.3.3. Topical

7.3.4. Rectal

7.4. Market Attractiveness, by Route of Administration

8. Global Hydrocortisone Market Analysis and Forecast, by Distribution Channel

8.1. Introduction

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Distribution Channel, 2018–2028

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Market Attractiveness, by Distribution Channel

9. Global Hydrocortisone Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness, by Region

10. North America Hydrocortisone Market Analysis and Forecast

10.1. Introduction

10.2. Market Value Forecast, by Indication, 2018–2028

10.2.1. Adrenocortical Insufficiency

10.2.2. Adrenergic Syndrome

10.2.3. High Blood Calcium

10.2.4. Thyroiditis

10.2.5. Rheumatoid Arthritis

10.2.6. Dermatitis

10.2.7. Asthma and Chronic Obstructive Pulmonary Disease (COPD)

10.2.8. Others

10.3. Market Value Forecast, by Route of Administration, 2018–2028

10.3.1. Parenteral

10.3.2. Oral

10.3.3. Topical

10.3.4. Rectal

10.4. Market Value Forecast, by Distribution Channel, 2018–2028

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. Market Value Forecast, by Country, 2018–2028

10.5.1. U.S.

10.5.2. Canada

10.6. Market Attractiveness Analysis

10.6.1. By Indication

10.6.2. By Route of Administration

10.6.3. By Distribution Channel

10.6.4. By Country

11. Europe Hydrocortisone Market Analysis and Forecast

11.1. Introduction

11.2. Market Value Forecast, by Indication, 2018–2028

11.2.1. Adrenocortical Insufficiency

11.2.2. Adrenergic Syndrome

11.2.3. High Blood Calcium

11.2.4. Thyroiditis

11.2.5. Rheumatoid Arthritis

11.2.6. Dermatitis

11.2.7. Asthma and Chronic Obstructive Pulmonary Disease (COPD)

11.2.8. Others

11.3. Market Value Forecast, by Route of Administration, 2018–2028

11.3.1. Parenteral

11.3.2. Oral

11.3.3. Topical

11.3.4. Rectal

11.4. Market Value Forecast, by Distribution Channel, 2018–2028

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online Pharmacies

11.5. Market Value Forecast, by Country/Sub-region, 2018–2028

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Market Attractiveness Analysis

11.6.1. By Indication

11.6.2. By Route of Administration

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region

12. Asia Pacific Hydrocortisone Market Analysis and Forecast

12.1. Introduction

12.2. Market Value Forecast, by Indication, 2018–2028

12.2.1. Adrenocortical Insufficiency

12.2.2. Adrenergic Syndrome

12.2.3. High Blood Calcium

12.2.4. Thyroiditis

12.2.5. Rheumatoid Arthritis

12.2.6. Dermatitis

12.2.7. Asthma and Chronic Obstructive Pulmonary Disease (COPD)

12.2.8. Others

12.3. Market Value Forecast, by Route of Administration, 2018–2028

12.3.1. Parenteral

12.3.2. Oral

12.3.3. Topical

12.3.4. Rectal

12.4. Market Value Forecast, by Distribution Channel, 2018–2028

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Market Value Forecast, by Country/Sub-region, 2018–2028

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Market Attractiveness Analysis

12.6.1. By Indication

12.6.2. By Route of Administration

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Hydrocortisone Market Analysis and Forecast

13.1. Introduction

13.2. Market Value Forecast, by Indication, 2018–2028

13.2.1. Adrenocortical Insufficiency

13.2.2. Adrenergic Syndrome

13.2.3. High Blood Calcium

13.2.4. Thyroiditis

13.2.5. Rheumatoid Arthritis

13.2.6. Dermatitis

13.2.7. Asthma and Chronic Obstructive Pulmonary Disease (COPD)

13.2.8. Others

13.3. Market Value Forecast, by Route of Administration, 2018–2028

13.3.1. Parenteral

13.3.2. Oral

13.3.3. Topical

13.3.4. Rectal

13.4. Market Value Forecast, by Distribution Channel, 2018–2028

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Market Value Forecast, by Country/Sub-region, 2018–2028

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis

13.6.1. By Indication

13.6.2. By Route of Administration

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region

14. Middle East & Africa Hydrocortisone Market Analysis and Forecast

14.1. Introduction

14.2. Market Value Forecast, by Indication, 2018–2028

14.2.1. Adrenocortical Insufficiency

14.2.2. Adrenergic Syndrome

14.2.3. High Blood Calcium

14.2.4. Thyroiditis

14.2.5. Rheumatoid Arthritis

14.2.6. Dermatitis

14.2.7. Asthma and Chronic Obstructive Pulmonary Disease (COPD)

14.2.8. Others

14.3. Market Value Forecast, by Route of Administration, 2018–2028

14.3.1. Parenteral

14.3.2. Oral

14.3.3. Topical

14.3.4. Rectal

14.4. Market Value Forecast, by Distribution Channel, 2018–2028

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Market Value Forecast, by Country/Sub-region, 2018–2028

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Market Attractiveness Analysis

14.6.1. By Indication

14.6.2. By Route of Administration

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region

15. Company Profiles

15.1. Pfizer, Inc.

15.1.1.1. Company Overview

15.1.1.2. Company Financials

15.1.1.3. Growth Strategies

15.1.1.4. SWOT Analysis

15.2. Novartis AG

15.2.1.1. Company Overview

15.2.1.2. Company Financials

15.2.1.3. Growth Strategies

15.2.1.4. SWOT Analysis

15.3. Mylan N.V.

15.3.1.1. Company Overview

15.3.1.2. Company Financials

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.4. Hikma Pharmaceuticals Plc

15.4.1.1. Company Overview

15.4.1.2. Company Financials

15.4.1.3. Growth Strategies

15.4.1.4. SWOT Analysis

15.5. GlaxoSmithKline plc

15.5.1.1. Company Overview

15.5.1.2. Company Financials

15.5.1.3. Growth Strategies

15.5.1.4. SWOT Analysis

15.6. Cipla Inc.

15.6.1.1. Company Overview

15.6.1.2. Company Financials

15.6.1.3. Growth Strategies

15.6.1.4. SWOT Analysis

15.7. Sun Pharmaceutical Industries Ltd.

15.7.1.1. Company Overview

15.7.1.2. Company Financials

15.7.1.3. Growth Strategies

15.7.1.4. SWOT Analysis

15.8. Abbott Laboratories

15.8.1.1. Company Overview

15.8.1.2. Company Financials

15.8.1.3. Growth Strategies

15.8.1.4. SWOT Analysis

15.9. Bayer AG

15.9.1.1. Company Overview

15.9.1.2. Company Financials

15.9.1.3. Growth Strategies

15.9.1.4. SWOT Analysis

List of Tables

Table 01: Comparison of Regulatory Requirements for Generic Drugs Dossier Submission in the U.S. and Canada

Table 02: Global Hydrocortisone Market Value (US$ Mn) Forecast, by Indication, 2018–2028

Table 03: Global Hydrocortisone Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

Table 04: Global Hydrocortisone Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

Table 05: Global Hydrocortisone Market Value (US$ Mn) Forecast, by Region, 2018–2028

Table 06: North America Hydrocortisone Market Value (US$ Mn) Forecast, by Indication, 2018–2028

Table 07: North America Hydrocortisone Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

Table 08: North America Hydrocortisone Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

Table 09: North America Hydrocortisone Market Value (US$ Mn) Forecast, by Country, 2018–2028

Table 10: Europe Hydrocortisone Market Value (US$ Mn) Forecast, by Indication, 2018–2028

Table 11: Europe Hydrocortisone Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

Table 12: Europe Hydrocortisone Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

Table 13: Europe Hydrocortisone Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

Table 14: Asia Pacific Hydrocortisone Market Value (US$ Mn) Forecast, by Indication, 2018–2028

Table 15: Asia Pacific Hydrocortisone Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

Table 16: Asia Pacific Hydrocortisone Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

Table 17: Asia Pacific Hydrocortisone Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

Table 18: Latin America Hydrocortisone Market Value (US$ Mn) Forecast, by Indication, 2018–2028

Table 19: Latin America Hydrocortisone Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

Table 20: Latin America Hydrocortisone Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

Table 21: Latin America Hydrocortisone Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

Table 22: Middle East & Africa Hydrocortisone Market Value (US$ Mn) Forecast, by Indication, 2018–2028

Table 23: Middle East & Africa Hydrocortisone Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028

Table 24: Middle East & Africa Hydrocortisone Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028

Table 25: Middle East & Africa Hydrocortisone Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028

---